Exifone Is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration-Reference-Cited by-同舟云学术

Exifone Is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration

Published:2021-01-08 Issue:2 Volume:12 Page:271-284
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Patnaik Debasis¹²^ORCID,Pao Ping-Chieh³,Zhao Wen-Ning¹²^ORCID,Silva M. Catarina¹²,Hylton Norma K.¹²,Chindavong Peter S.¹²,Pan Ling³,Tsai Li-Huei³,Haggarty Stephen J.¹²^ORCID

Affiliation:

1. Chemical Neurobiology Laboratory, Center for Genomic Medicine, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, 185 Cambridge Street, Boston, Massachusetts 02114, United States

2. Departments of Psychiatry & Neurology, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts 02114, United States

3. Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

Funder

National Institute of Neurological Disorders and Stroke

Alzheimer's Association

Massachusetts General Hospital

National Institute on Aging

Glenn Foundation for Medical Research

Rainwater Charitable Foundation

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00308

Reference49 articles.

1. Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity

2. HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer’s disease

3. Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons

4. Tsai, L.H., Pan, L., Haggarty, S. J., and Patnaik, D. (Jan 1, 2019) Activators of class I histone deacetylases (HDACs) and uses thereof, US Patent 10,167,277.

5. Gazave, J. M., Rancurel, A., and Grenier, G. (March 29, 1977) Certain biphenyl derivatives used to treat disorders caused by increased capillary permeability, US Patent 4,015,017A.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systems-biology approach connects aging mechanisms with Alzheimer’s disease pathogenesis;2024-03-17

2. Unlocking the Epigenetic Symphony: Histone Acetylation’s Impact on Neurobehavioral Change in Neurodegenerative Disorders;Epigenomics;2024-02-07

3. Traumatic brain injury-associated epigenetic changes and the risk for neurodegenerative diseases;Frontiers in Neuroscience;2023-09-19

4. Influential factors of stroke: depression, Alzheimer's disease;International Conference on Modern Medicine and Global Health (ICMMGH 2023);2023-09-07

5. Design, Synthesis, and Proof of Concept of Balanced Dual Inhibitors of Butyrylcholinesterase (BChE) and Histone Deacetylase 6 (HDAC6) for the Treatment of Alzheimer’s Disease;ACS Chemical Neuroscience;2023-08-10